Cargando…
RNA N(6)-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer
BACKGROUND: N(6)-methyladenosine is the most abundant eukaryotic mRNA modification and alters a wide range of cellular processes in cancer. Therefore, defining the molecular details are critical for understanding the regulatory mechanism of m(6)A modification. RESULTS: We found that METTL3, a core m...
Autores principales: | Yu, Tao, Wu, Fuxia, Jia, Yan, Zhang, Xue, Qi, Xiaozhen, Jin, Zeyuan, Hao, Tongxin, Zhao, Jianing, Liu, Ziyu, Wang, Chaokun, Niu, Minmin, Yue, Qin, Li, Min, Liu, Yankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790124/ https://www.ncbi.nlm.nih.gov/pubmed/36566195 http://dx.doi.org/10.1186/s13578-022-00937-w |
Ejemplares similares
-
DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A
por: Hu, Yang, et al.
Publicado: (2019) -
Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020) -
PSMC3 promotes RNAi by maintaining AGO2 stability through USP14
por: Jia, Yan, et al.
Publicado: (2022) -
The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022) -
Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)